Vicore Pharma Holding AB (OSTO:VICO) Institutional Ownership: 22.25% (As of Jul. 18, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:VICO Vicore Pharma Holding AB OSTO:VICO
30 GF Score
Price kr11.36
! 2 Warning Signs
View Full Analysis

What is Vicore Pharma Holding AB Institutional Ownership?

Vicore Pharma Holding AB OSTO:VICO -0.87% 30 Institutional Ownership is 22.25% as of Jul. 18, 2026. GuruFocus rates OSTO:VICO with a GF Score™ of 30/100. The stock has 2 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Vicore Pharma Holding AB's institutional ownership is 22.25%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Vicore Pharma Holding AB's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Vicore Pharma Holding AB's Float Percentage Of Total Shares Outstanding is 0.00%.

Vicore Pharma Holding AB Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Vicore Pharma Holding AB's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vicore Pharma Holding AB Institutional Ownership Chart

Vicore Pharma Holding AB Historical Data

The historical data trend for Vicore Pharma Holding AB can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 21.16 21.11 24.64 22.64 22.71 22.82 22.18 22.17 22.42 22.25
OSTO:VICO
30GF Score
Vicore Pharma Holding AB OSTO:VICO
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vicore Pharma Holding AB Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 22.25% mean?
Vicore Pharma Holding AB (OSTO:VICO) has a Institutional Ownership of 22.25% as of Jul. 18, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Vicore Pharma Holding AB and its competitors.
Is Vicore Pharma Holding AB's Institutional Ownership too high?
Vicore Pharma Holding AB's current Institutional Ownership is 22.25%. Overall, Vicore Pharma Holding AB has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Vicore Pharma Holding AB's Institutional Ownership compare to VRTX and REGN?
Vicore Pharma Holding AB's Institutional Ownership of 22.25% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Vicore Pharma Holding AB and its competitors. Vicore Pharma Holding AB's current Institutional Ownership is 22.25%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vicore Pharma Holding AB stock overvalued right now?
Vicore Pharma Holding AB (OSTO:VICO) has a current Institutional Ownership of 22.25%. The current Institutional Ownership is 22.25%. Vicore Pharma Holding AB's overall GF Score™ is 30/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Vicore Pharma Holding AB (OSTO:VICO), the current Institutional Ownership is 22.25% as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vicore Pharma Holding AB Business Description

Other Exchanges 6Y4:Germany
Address Kornhamnstorg 53, Stockholm, SWE, 111 27
Vicore Pharma Holding AB is a clinical-stage biopharmaceutical company developing a new class of disease-modifying therapies for respiratory and fibrotic diseases, including idiopathic pulmonary fibrosis (IPF). Its main program, buloxibutid, is an oral angiotensin II type 2 receptor agonist that has received Orphan Drug and Fast Track designation from the U.S. Food and Drug Administration and is currently being evaluated in the 52-week Phase 2b ASPIRE trial in IPF. Currently, Vicore is operating mainly in Sweden.
30GF Score

Get the complete analysis for OSTO:VICO

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr11.36
Price